Skip to content

A Randomized Trial of NSAID Dosing Strategies

A Randomized Trial of NSAID Dosing Strategies

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05239767
Enrollment
407
Registered
2022-02-15
Start date
2022-06-01
Completion date
2023-04-24
Last updated
2023-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain, Musculoskeletal Pain

Brief summary

This study will compare the efficacy of two different non-steroidal anti-inflammatory drugs (NSAIDs) ketorolac and ibuprofen for people with acute moderate or severe musculoskeletal pain. The investigators will also determine whether taking acetaminophen prior to the NSAID impacts efficacy

Interventions

DRUGNSAID

We will administer oral NSAIDs

Sponsors

Montefiore Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

NSAID will be masked. Acetaminophen or no acetaminophen will not

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Acute musculoskeletal pain: Any pain attributable to muscles, bones, joints, tendons, ligaments or supporting structures, as determined by the clinical team, of 10 days duration or less. Prior to the onset of acute pain, patients cannot have experienced pain in the same body region during the prior six months * Pain has to be described as moderate or severe, when the patient is asked if the pain is mild, moderate or severe in intensity

Exclusion criteria

* Contraindication to NSAIDs (allergy to NSAID or allergy to aspirin without history of tolerating NSAIDs, history of gastrointestinal bleeding, daily medication for gastritis or PUD, chronic kidney disease 2-5, heart failure) * Contraindication to acetaminophen (hepatitis or cirrhosis) * Use of an NSAID within the previous eight hours * Use of acetaminophen within the previous eight hours * Chronic pain, defined as any pain on \>50% of days for at least 3 months prior to onset of acute pain * Recurrent pain in the same body part as the presenting complaint

Design outcomes

Primary

MeasureTime frameDescription
Failure to achieve a minimum clinically important differenceTwo hoursFailure to improve by at least 1.3 points on a 0-10 pain scale

Secondary

MeasureTime frameDescription
0-10 pain scoreOne and two hours after medication administrationImprovement on 0-10 pain
Ordinal pain scaleOne and two hours after medication administrationThe investigators will determine the frequency of obtaining pain levels of mild and none on a scale of severe, moderate', mild, or none
Epigastric painTwo hours after medication administrationParticipants will be asked if the medication caused stomach pain. Response options are no, a little, a lot

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026